Veru Inc. (NASDAQ:VERU) Financings

Veru Inc.

Financings

RaiseDate
Public offering of common stock (or pre-funded warrants) with accompanying Series A and Series B warrants
Closed: US$23.4M raised · US$3 a share · Canaccord Genuity LLC +1
Dealers: Canaccord Genuity LLC (co-lead), Oppenheimer & Co. Inc. (co-lead)
Use of proceeds: To start the Phase 2b PLATEAU clinical trial of enobosarm
Dec 17, 2025

Read by 6ix AI from the company's releases